DoH, Takeda Pharmaceuticals ink strategic partnership to advance rare diseases, oncology research

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with Takeda Pharmaceuticals, a values-based biopharmaceutical company with a Japanese Heritage, during the BIO International Convention 2024 in San Diego, US